Cynapsus Therapeutics Inc.
cynapsus.ca
Neurology & CNS Therapeutics
Prescription Drugs
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
Investors Overview Management Team Board of Directors Clinical Advisors Strategic Collaborations (MJFF) Contact Us About For important information regarding this website and this video please click here.
News
Buyout Buzz Sends Cynapsus Therapeutics Inc (CYNA) to Record High - Schaeffer's Investment Research
Cynapsus Therapeutics Inc (NASDAQ:CYNA) agreed to be acquired in a $624 million all-cash deal with Sunovion Pharmaceuticals
Read more
Report
Cynapsus Therapeutics Announces Positive Phase 3 Dose Titration Phase Results with APL-130277 for the Treatment of OFF Episodes in Patients with Parkinson
-- Webcast with accompanying slides to discuss these findings tomorrow at 7:30 a.m. Eastern time Top-line CTH-300 results expected in late Q3 or early Q4 -- TORONTO, July 18, 2016 (GLOBE NEWSWIRE) -- Cynapsus ...
Read more
Report
Cynapsus Therapeutics Enrolls First Patient in Pivotal Phase 3 Efficacy Study Evaluating Sublingual, Film Strip Delivery of Apomorphine to TurnParkinson's Disease Patients from ...
Read more
Report
Venture-backed Cynapsus Therapeutics files for NASDAQ IPO
Canadian specialty pharmaceutical company Cynapsus Therapeutics Inc has registered with U.S. securities regulators and filed an application to list on the NASDAQ Capital Market. The timing, number of shares and price per share of the proposed offering hav
Read more
Report
Cynapsus Therapeutics Provides Clinical and Regulatory Update for APL-130277 for the Acute Rescue of OFF Motor Symptoms of Parkinson's Disease Business Wire
Read more
Report
Cynapsus Therapeutics
Cynapsus Therapeutics Inc. today announced that its APL-130277 for Parkinson
Read more
Report
Cynapsus Therapeutics Inc. : Cynapsus Therapeutics Announces Change of Auditor
PRESS RELEASE Cynapsus Therapeutics Announces Change of Auditor September 19, 2014 TORONTO - Cynapsus Therapeutics Inc. ("Cynapsus" or the "Company") (TSX-V: CTH) (OTCQX: CYNAF) announces ...
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Toronto
Canada
HQ
Cynapsus Therapeutics Inc. Corporate Headquarters
828 Richmond Street West, Toronto, ON. M6J 1C9, Canada